trial

Childhood Maltreatment, Traumatic Experiences and Stress-associated Parameters in Schizophrenia Spectrum Disorders

NCTId NCT03730831
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 10 (actual)
Sponsored by University of Konstanz
Primary completion 2022-10-24
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2018-01-01
Primary completion
2022-10-24
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Narrative Exposure Therapy

Sponsors

University of KonstanzLead Sponsor
Centre for Psychiatry Reichenau, GermanyCollaborator

Sites

1 total
Konstanz, Germany

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2022-10-24
Status
COMPLETED
relationships
The graph out of here
drug
Narrative Exposure Therapy
drug
lead_sponsor
University of Konstanz
company
collaborator
Centre for Psychiatry Reichenau, Germany
company
indication
PTSD
indication
Schizophrenia Spectrum Disorder
indication
Stress Disorders, Post-Traumatic
indication